Status:
COMPLETED
Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis
Lead Sponsor:
University of North Carolina, Charlotte
Collaborating Sponsors:
Teva Branded Pharmaceutical Products R&D, Inc.
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if an herbal over-the-counter cream can decrease skin site reactions in multiple sclerosis patients who currently take either Betaseron, Copaxone or Rebif as ...
Detailed Description
Skin site reactions account for one of the most likely reasons for discontinuation of subcutaneous injections of MS medications. It is imperative that additional methods be determined to decrease the ...
Eligibility Criteria
Inclusion
- Participants must demonstrate redness of skin site reactions
- Must demonstrate accurate injection technique prior to initiating the study
Exclusion
- Cannot read the flexible measure and record the results.
- Are diagnosed with secondary progressive, primary progressive or Devic's MS.
- Are not taking one of the three subcutaneous injections (Betaseron®, Copaxone® or Rebif®).
- Are pregnant.
- Are younger than 18 years of age.
- Are using combination therapy (e.g., 2 of the immunomodulators, chemotherapy)
- Have allergies to any topical creams used on skin.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00972062
Start Date
June 1 2009
End Date
March 1 2010
Last Update
March 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Charlotte
Charlotte, North Carolina, United States, 28223